Find your path to Kevin
275 people in our graph share verified history with Kevin — schools, employers, funds. One of them is your warm intro.
André DuboisunlockedKevin: together at Index Ventures (2006–2016)
×11Kevin: together at Index Ventures
About
Co-founder and Senior Advisor at Medicxi who previously spent 13 years as a Partner at Index Ventures, where he originated its first asset-centric investment and led Medicxi's investment in Impact Biomedicines. Earlier he was Research Director and CTO at Cambridge Antibody Technology, contributing to antibodies now marketed as Humira and Benlysta.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Experience
- Medicxi VenturesGeneral Partnercurrent2016 — presentLondon Area, United Kingdom
- Index VenturesVenture Partner2010 — 2016
- Index VenturesVenture Advisor2003 — 2010
- PanGenetics BVCEO2005 — 2010
- Ash Biotech ConsultingOwner2003 — 2010
- Cambridge Antibody TechnologyChief Technology Officer1990 — 2003
Skills & more
Vaccines11Technology Transfer36Drug Development63Lifesciences19Biotechnology51Start-ups21Venture Capital29R&D13Biochemistry9Drug Discovery16Antibodies9Molecular Biology6
+12 more
Clinical DevelopmentImmunologyBiopharmaceuticalsGenomicsCellBioinformaticsMedical DevicesPatentsProtein ChemistryCommercializationCorporate DevelopmentLicensingFrom Kevin's professional profile.
Investments
Led
Impact Biomedicines
Board seats
Crescendo BiologicsLevicept
Investor
PanGenetics
Per the firm's website.
Colleagues at Medicxi
Frequently asked questions
- Who is Kevin Johnson?
- Co-founder and Senior Advisor at Medicxi who previously spent 13 years as a Partner at Index Ventures, where he originated its first asset-centric investment and led Medicxi's investment in Impact Biomedicines. Earlier he was Research Director and CTO at Cambridge Antibody Technology, contributing to antibodies now marketed as Humira and Benlysta.
- Where does Kevin Johnson work?
- Kevin Johnson is Co-founder & Senior Advisor at Medicxi.
- What does Kevin Johnson invest in?
- Kevin Johnson invests in Biotech, Healthtech, Medical Devices.
- What boards does Kevin Johnson sit on?
- Kevin Johnson holds tracked board seats at Crescendo Biologics, Levicept.
- What companies has Kevin Johnson invested in?
- Investments tracked here include Impact Biomedicines, PanGenetics.
- Where did Kevin Johnson go to school?
- Kevin Johnson studied at University of Cambridge (PhD, Molecular Parasitology); The University of Edinburgh (BSc (hons), Molecular Biology); University of Melbourne (Post Doc, Vaccines).
- Does Kevin Johnson lead rounds?
- Yes — Kevin Johnson has led 1 tracked investment.
Same school
Also attended University of Cambridge1,604
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosFounder and Managing Partner of VerdictGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
+ 1,598 more
Also attended The University of Edinburgh404
Sofia DolfeInvestor at Index VenturesFreya Svedberg-KeatingInvestor at MedicxiPatrick NorrisGeneral Partner at Notion CapitalSarah MandersonLegal Director at Hoxton VenturesPolly BarnesInvestor at EQT VenturesClay RowlandInvestment Associate at Mission Biocapital
+ 398 more
Also attended University of Melbourne385
Cameron AdamsCo-founder & Chief Product Officer of CanvaEsther GilmoreGlobal Head of the Client Team at Generation Investment ManagementMark MillsClient Team Member at Generation Investment ManagementPaulInvestor at Square Peg CapitalClarissa KartikaAssociate, Investment at Vertex Ventures Sea Management Pte. Ltd.Rikke Kjær DamgaardAssociate at SEED Capital Denmark
+ 379 more
Shared employers
Also worked at Index Ventures136
Danny RimerPartner at Index VenturesAdrianna MaInvestor at Index VenturesAli Fisher SweetInvestor at Index VenturesAna AndreescuInvestor at Index VenturesAndré DuboisInvestor at Index VenturesAvron MarcusInvestor at Index Ventures
+ 130 more
